Crawford, Alyson2015-11-252015-11-2520152015http://hdl.handle.net/10393/33365http://dx.doi.org/10.20381/ruor-3970Purpose: Assess for an association of wait times to melanoma treatment with overall survival. Methods: Retrospective review of Ontario patients with melanoma, with descriptive and survival analyses. Results: Median wait times were 43 days (interquartile range (IQR), 24-64) for wide local excision (WLE), 59 days (IQR, 41-81) for sentinel lymph node biopsy (SNB), 63 days (IQR, 43-91) for lymph node dissection (LND), 124 days (IQR, 96-150) for medical therapy, and 130 days (IQR, 89.5-157.5) for radiation therapy. In multivariate analysis, wait times to treatment were not associated with overall survival for WLE (hazard ratio (HR), 0.97; 95% confidence interval (CI), 0.87-1.08; p=0.62), SNB (HR, 0.89; 95% CI, 0.74-1.07; p=0.21), LND (HR, 0.99; 95% CI, 0.89-1.11; p=0.92), medical therapy (HR, 0.94; 95% CI, 0.80-1.10; p=0.41) or radiation therapy (HR, 0.80; 95% CI, 0.61-1.03; p=0.08). Conclusion: Overall survival for patients with melanoma was not associated with wait times to surgical, medical or radiation therapy.enMelanomaWait timeSurvivalSurgeryThesis